Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease

Many genetic risk factors for Parkinson’s disease have lipid-related functions and lipid-modulating drugs such as statins may be protective against Parkinson’s disease. Moreover, the hallmark Parkinson’s disease pathological protein, α-synuclein, has lipid membrane function and pathways dysregulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Galper, Jasmin, Dean, Nicholas J, Pickford, Russell, Lewis, Simon J G, Halliday, Glenda M, Kim, Woojin S, Dzamko, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586542/
https://www.ncbi.nlm.nih.gov/pubmed/35551349
http://dx.doi.org/10.1093/brain/awac176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586542/
https://www.ncbi.nlm.nih.gov/pubmed/35551349
http://dx.doi.org/10.1093/brain/awac176

Ejemplares similares